Furthermore, in a recent large representative diagnostic cohort of MDS patients, 1% of patients were found to be carriers of likely pathogenic UBA1 mutations, underlying the importance to consider UBA1 mutations in the diagnostic workup for MDS and MDS/VEXAS overlap (20). The gene discussed is UBA1; the disease is myelodysplastic syndrome.